Testing effectiveness (Phase 2)Study completedNCT01267253
What this trial is testing
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer
Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
Gynecologic Oncology Group 31